News

Medicenna Therapeutics to Share Insights at Prominent Health Conference

Medicenna Therapeutics to Share Insights at Prominent Health Conference

Medicenna Therapeutics Joins Key Healthcare Event

TORONTO and HOUSTON — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a pioneering clinical-stage immunotherapy company, is excited to announce participation in a significant healthcare opportunity conference. This event focuses on the development of innovative Superkines targeted at combating cancer and addressing autoimmune diseases.

Details on the Healthcare Conference

Dr. Fahar Merchant, the esteemed President and CEO of Medicenna, is set to engage in discussions at the upcoming ROTH 4th Annual Healthcare Opportunities Conference. Taking place at the prestigious Metropolitan Club, this event promises enriching discourse from October 8-9.

Event Overview

This year’s conference format features 1-on-1 and small group meetings that allow institutional investors unparalleled interaction with executive management. It’s an excellent opportunity for guests to gain valuable insights into the innovations and developments shaping Medicenna’s efforts in the therapeutic landscape.

About ROTH

ROTH is a distinguished investment bank dedicated to fostering relationships and supporting growth companies. Their comprehensive service offerings include capital raising, equity research, macroeconomic analysis, and corporate access, all tailored to enhance investor engagement.

ROTH’s Commitment

Headquartered in Newport Beach, ROTH is a renowned employee-owned firm with a network of offices across the U.S., dedicated to cultivating partnerships that drive growth and innovation.

Medicenna’s Innovative Approaches

Medicenna Therapeutics is at the forefront of immunotherapy innovation. Their research primarily emphasizes the development of novel Superkines such as IL-2, IL-4, and IL-13, as well as first-of-their-kind Empowered Superkines. A highlight of their portfolio is MDNA11, a long-acting IL-2 Superkine designed to preferentially stimulate cancer-killing effector T cells while avoiding unwanted side effects associated with traditional IL-2 therapies.

The Advancements of Bizaxofusp

Medicenna has also pioneered bizaxofusp (formerly MDNA55), an IL-4 Empowered Superkine that has shown promise through five clinical trials, including a Phase 2b trial targeting recurrent glioblastoma (GBM), a notoriously aggressive form of brain cancer. Recognition of its potential has led to Fast Track and Orphan Drug designations from the FDA, underscoring its importance in modern therapeutic strategies.

Future Directions for Medicenna

In addition to their current initiatives, Medicenna is investing in early-stage BiSKITs™ and the T-MASK™ programs. These innovative therapies are being developed with the intent to target and activate immunologically “cold” tumors, which previously have been challenging to treat effectively. This commitment to overcoming current limitations in cancer treatment exemplifies Medicenna's dedication to advancing healthcare.

Stay Updated with Medicenna

For those eager to learn more about Medicenna’s groundbreaking work in immunotherapy, more information can be found on their official website. Follow them on social media platforms like Twitter and LinkedIn for real-time updates and insights.

Frequently Asked Questions

What is Medicenna Therapeutics known for?

Medicenna Therapeutics is renowned for its clinical-stage immunotherapy products focused on developing Superkines for cancer and autoimmune disease treatments.

Who will represent Medicenna at the conference?

Dr. Fahar Merchant, President and CEO of Medicenna, will participate and share insights during the ROTH Healthcare Opportunities Conference.

Where is the ROTH conference being held?

The conference will take place at the Metropolitan Club, located in New York City.

What are the main therapies Medicenna is developing?

Medicenna is developing novel Superkines such as MDNA11 and bizaxofusp, aimed at treating various cancers and improving immune responses.

How can I learn more about Medicenna’s work?

You can learn more by visiting their website or following them on social media for the latest updates on their research and clinical trials.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 28

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 161

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 78

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 343

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 77

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 342

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 86

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 24

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 207

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Mercy Medical Center Nurses Mobilize for Patient Safety Picket

Updated Category News Views 35

Nurses Standing Together for Patient Safety Nurses at Mercy Medical Center are uniting for a cause that affects them profoundly: the safety of their patients and the workplace. With issues surrounding unsafe staffing and deteriorating care conditions, nurses represented by the Massachusetts Nurses Association plan to hold an informational picket. This demonstration is not...

Continue Reading
Massive Merger: Qorvo and Skyworks Unite for Future Innovations

Updated Category News Views 306

Overview of the Strategic Merger In an exciting development in the technology sector, shares of Qorvo, Inc. (NASDAQ: QRVO) and Skyworks Solutions, Inc. (NASDAQ: SWKS) are experiencing a notable surge after announcing their intent to merge. This deal, which values the combined entity at approximately $22 billion, marks a significant step forward in the realm of...

Continue Reading
Oryzon Genomics Announces Corporate Updates for September

Updated Category News Views 178

Oryzon Genomics to Share Updates on Corporate Progress Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a leading clinical-stage biopharmaceutical company dedicated to epigenetic therapies for critical medical needs, is set to present its latest corporate updates at several major international events. These important gatherings scheduled for September will showcase...

Continue Reading
Envision Energy Launches Innovative Energy Storage Solution

Updated Category News Views 363

Introducing the EN 8 Pro: A Revolution in Energy Storage Envision Energy, a leader in sustainable technology, has made a significant breakthrough in energy management with the launch of its EN 8 Pro 8MWh DC Liquid-Cooled Energy Storage System. This innovative setup is set to establish new industry standards in safety, efficiency, and environmental adaptability. Designed...

Continue Reading
Beard Papa's Teams Up for Exciting Zenless Zone Zero Launch

Updated Category News Views 528

Beard Papa's Exciting Flavor Collaboration Begins Beard Papa's, renowned for its delectable cream puffs and irresistible custard fillings, is thrilled to announce a nationwide collaboration with Zenless Zone Zero. This partnership will launch an exciting in-game event that will allow fans to experience the unique flavors inspired by the action-RPG sensation from...

Continue Reading